Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA148390
Max Phase: Preclinical
Molecular Formula: C8H10ClN5O2
Molecular Weight: 243.65
Molecule Type: Small molecule
Associated Items:
ID: ALA148390
Max Phase: Preclinical
Molecular Formula: C8H10ClN5O2
Molecular Weight: 243.65
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C/N=C(\NCc1ccc(Cl)nc1)N[N+](=O)[O-]
Standard InChI: InChI=1S/C8H10ClN5O2/c1-10-8(13-14(15)16)12-5-6-2-3-7(9)11-4-6/h2-4H,5H2,1H3,(H2,10,12,13)
Standard InChI Key: SWHRDLPFZQFSLS-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 243.65 | Molecular Weight (Monoisotopic): 243.0523 | AlogP: 0.59 | #Rotatable Bonds: 3 |
Polar Surface Area: 92.45 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.82 | CX Basic pKa: 7.40 | CX LogP: 0.78 | CX LogD: 0.47 |
Aromatic Rings: 1 | Heavy Atoms: 16 | QED Weighted: 0.27 | Np Likeness Score: -1.61 |
1. Kagabu S, Maienfisch P, Zhang A, Granda-Minones J, Haettenschwiler J, Kayser H, Maetzke T, Casida JE.. (2000) 5-Azidoimidacloprid and an acyclic analogue as candidate photoaffinity probes for mammalian and insect nicotinic acetylcholine receptors., 43 (26): [PMID:11150171] [10.1021/jm000240p] |
2. Kagabu S, Hibi M, Nishimura K.. (2005) Prodrug-oriented molecular design of neonicotinoids: preparation of imidacloprid-related 5,5-dimethoxy-1,3-diazacyclohexane derivatives and their insecticidal activity., 69 (4): [PMID:15849408] [10.1271/bbb.69.705] |
3. Zhang A, Kayser H, Maienfisch P, Casida JE.. (2000) Insect nicotinic acetylcholine receptor: conserved neonicotinoid specificity of [(3)H]imidacloprid binding site., 75 (3): [PMID:10936213] [10.1046/j.1471-4159.2000.751294.x] |
4. Ihara M, Brown LA, Ishida C, Okuda H, Sattelle DB, Matsuda K. (2006) Actions of imidacloprid, clothianidin and related neonicotinoids on nicotinic acetylcholine receptors of American cockroach neurons and their relationships with insecticidal potency, 31 (1): [10.1584/jpestics.31.35] |
Source(1):